quantitative
For people with obesity and heart disease, a weekly semaglutide injection lowers the chance of having a heart attack, stroke, or dying from heart problems by 20%, even if their blood sugar doesn’t change.
Evidence from Studies
No evidence studies found yet.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.